What Researchers Did
Doctors reviewed cases of patients with pyoderma gangrenosum (PG), a painful skin ulcer condition that is hard to treat, and reported on outcomes when HBOT was added to standard care.
What They Found
One patient with treatment-resistant PG achieved full remission after receiving HBOT as an add-on therapy. When the same patient later had a flare and did not receive HBOT, achieving remission was significantly harder. The cases suggest HBOT may be a key part of getting this condition under control.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a single case report, so no conclusions about effectiveness can be drawn for the broader PG population.